SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF

The prognosis of breast cancer brain metastasis (BCBM) is extremely poor due to its resistance to conventional therapy. Elucidation of the molecular mechanisms of BCBM could contribute to the development of new therapeutic targets. In this study, we isolated RNA samples from primary breast cancer or...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Ther Oncolytics
Huvudupphovsmän: Xiao, Weikai, Zheng, Shaoquan, Xie, Xinhua, Li, Xing, Zhang, Lijuan, Yang, Anli, Wang, Jian, Tang, Hailin, Xie, Xiaoming
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Gene & Cell Therapy 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163054/
https://ncbi.nlm.nih.gov/pubmed/32322668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.03.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk